Description
17-phenyl trinor-13,14-dihydro PGA2 is a synthetic PG analog whose biological activity has not been widely reported. The PGF2α analog latanoprost, which bears the same lower side chain features, has been approved as a pharmaceutical for the treatment of glaucoma.{5338}
Formal name: 9-oxo-15R-hydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,10-dien-1-oic acid
Synonyms: 17-phenyl trinor-13,14-dihydro PGA2
Molecular weight: 370.5
CAS: 130209-80-2
Purity: ≥98%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway
